Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and … J Heide, S Schulte, M Kohsar, TT Brehm, M Herrmann, H Karsten, ... PLoS pathogens 17 (9), e1009842, 2021 | 46 | 2021 |
Humoral and cellular immune response after third and fourth SARS-CoV-2 mRNA vaccination in liver transplant recipients A Harberts, GM Schaub, DF Ruether, PM Duengelhoef, TT Brehm, ... Clinical Gastroenterology and Hepatology 20 (11), 2558-2566. e5, 2022 | 33 | 2022 |
High‐resolution analysis of individual spike peptide‐specific CD4+ T‐cell responses in vaccine recipients and COVID‐19 patients H Karsten, L Cords, T Westphal, M Knapp, TT Brehm, L Hermanussen, ... Clinical & translational immunology 11 (8), e1410, 2022 | 15 | 2022 |
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold … T Westphal, M Mader, H Karsten, L Cords, M Knapp, S Schulte, ... Frontiers in immunology 14, 1182504, 2023 | 9 | 2023 |
Broadening the horizon: potential applications of CAR-T cells beyond current indications H Karsten, L Matrisch, S Cichutek, W Fiedler, W Alsdorf, A Block Frontiers in Immunology 14, 1285406, 2023 | 7 | 2023 |
The Lübeck medication satisfaction questionnaire—a novel measurement tool for therapy satisfaction L Matrisch, Y Rau, H Karsten, H Graßhoff, G Riemekasten Journal of Personalized Medicine 13 (3), 505, 2023 | 3 | 2023 |
Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with … J Heide, S Schulte, M Kohsar, TT Brehm, M Herrmann, H Karsten, ... PLoS Pathogens 18 (1), e1010220, 2022 | 3 | 2022 |
Increase in Registered Acute Kidney Injuries in German Hospitals L Matrisch, H Karsten, J Schücke, Y Rau Cureus 15 (3), 2023 | 1 | 2023 |